Matthew Angel
CEO, President at Tempest Therapeutics, Inc. (TPST)
Purchase track record
Below average. Based on 2 purchases with a full 90 days of price history.
6
Avg. 90-day return-33.1%
vs. S&P 500-41.9%
Beat the market0%
Paper profit on buys−$648K
Total bought / sold$1.0M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 23SEC | TPSTTempest Therapeutics, Inc. | Buy | 231,482new position | $2.16 | $500K | -64.8% |
| Mar 25SEC | TPSTTempest Therapeutics, Inc. | Buy | 231,482new position | $2.16 | $500K | -64.8% |
- Buy
CEO, President Matthew Angel bought $500K of TPST at $2.16 — first open-market purchase in our records; opens a new position.
- Buy
CEO, President Matthew Angel bought $500K of TPST at $2.16 — opens a new position.